Phase I study of afatinib and radiotherapy (RT) with or without temozolomide (TMZ) in newly diagnosed glioblastoma (GB).

被引：0
|
作者：
Saran, Frank
Welsh, Liam
James, Allan
McBain, Catherine
Gattamaneni, Rao
Jefferies, Sarah
Harris, Fiona
Cseh, Agnieszka
Pemberton, Karine
Schaible, Jennifer
Bender, Shaun
Brada, Michael
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
[6] Boehringer Ingelheim Ltd, Bracknell, Berks, England
[7] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[8] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[9] Clatterbridge Canc Ctr NHS Fdn Trust, Bebington, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2036
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)
    Gan, Hui K.
    Fichtel, Lisa
    Lassman, Andrew B.
    Merrell, Ryan
    van den Bent, Martin
    Kumthekar, Priya
    Scott, Andrew M.
    Pedersen, Michelle
    Gomez, Erica
    Fischer, JuDee
    Ames, William
    Xiong, Hao
    Dudley, Matt
    Munasinghe, Wijith
    Roberts-Rapp, Lisa
    Ansell, Peter
    Holen, Kyle
    Reardon, David A.
    NEURO-ONCOLOGY, 2014, 16
  • [22] Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Grossman, S. A.
    Ye, X.
    Chamberlain, M. C.
    Mikkelsen, T.
    Batchelor, T. T.
    Desideri, S.
    Piantadosi, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [24] SAFETY RESULTS FROM AVAglio, A PHASE III RANDOMIZED STUDY OF BEVACIZUMAB (BEV) PLUS STANDARD COMBINATION TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    Chinot, Olivier L.
    Henriksson, Roger
    Mason, Warren
    Wick, Wolfgang
    Nishikawa, Ryo
    Dahr, Sunita
    Hilton, Magalie
    Garcia, Josep
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2013, 15 : 127 - 128
  • [25] EORTC Study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with or without PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma-Results of a phase I trial
    Brandes, A. A.
    Stupp, R.
    Hau, P.
    Sleijfer, S.
    Lacombe, D.
    Gorlia, T.
    Yun, H.
    Tosoni, A.
    Mirimanoff, R.
    van den Bent, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB])
    Phillips, Heidi
    Sandmann, Thomas
    Li, Congfen
    Cloughesy, Timothy Francis
    Chlnot, Olivier L.
    Wick, Wolfgang
    Nishikawa, Ryo
    Mason, Warren P.
    Henriksson, Roger
    Saran, Frank
    Lai, Albert
    Moore, Nicola
    Hegde, Priti S.
    Abrey, Lauren E.
    Bourgon, Richard
    Garcia, Josep
    Bais, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Phase II - Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations - Author reply
    Chinot, OL
    CANCER, 2004, 101 (12) : 2898 - 2899
  • [28] A phase I study of capecitabine and concurrent radiotherapy (RT) for patients with newly diagnosed glioblastoma multiforme (GBM).
    Newman, AJ
    Fiveash, J
    Rosenfeld, S
    Johnson, M
    Diasio, R
    Wang, W
    Cockrell-Donohue, AC
    Nabors, LB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 116S - 116S
  • [29] EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma
    Brandes, Alba A.
    Stupp, Roger
    Hau, Peter
    Lacombe, Denis
    Gorlia, Thierry
    Tosoni, Alicia
    Mirimanoff, Rene O.
    Kros, Johan M.
    van den Bent, Martin J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) : 348 - 354
  • [30] A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)
    Bota, Daniela
    Mason, Warren
    Kesari, Santosh
    Piccioni, David
    Aregawi, Dawit
    Desjardins, Annick
    Winograd, Benjamin
    Reich, Steven D.
    Levin, Nancy
    Trikha, Mohit
    NEURO-ONCOLOGY, 2017, 19 : 10 - 10
12345